Medical/Pharmaceuticals News & Press Release Distribution

Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patients

HANGZHOU and SHAOXING, China, March 25, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today the first clinical study using Ganovo®(danoprevir) to treat naive and experienced COVID-19 patients was published in medRxiv. The data from this small-sample clinical study showed ...

2020-03-25 08:28 3335

Precision NanoSystems Announces Partnership with Fujifilm for the Development and GMP Manufacturing of Nanoparticle Based Therapeutics

VANCOUVER, March 25, 2020 /PRNewswire/ -- Precision Nanosystems, Inc. (PNI), a global leader in enabling transformative nanomedicines announced today that the company entered into a license agreement with FUJIFILM Corporation to adopt PNI's NanoAssemblr™ technology and complete suite of instrumen...

2020-03-25 08:00 1689

MORE Health Launches Coronavirus COVID-19 Self-Assessment

SAN MATEO, Calif., March 24, 2020 /PRNewswire/ -- On March 24, 2020, MORE Health, a Silicon Valley headquartered cross-border telemedicine company, is launching a premier, freely available self-assessment tool for COVID-19 in six languages atcovid19.morehealth.com. The MORE COVID-19 Self-Assessm...

2020-03-24 21:00 3258

Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted

SHENZHEN, China, March 24, 2020 /PRNewswire/ -- On March 23th, 2020, Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company's application for Investigational New Drug (IND) of CS12192 has been accepted by Center for Drug Evaluation, ...

2020-03-24 19:25 1655

WuXi AppTec Reports Strong 2019 Annual Results

Revenue Growth Accelerated 33.9% Year-Over-Year to RMB12,872 Million Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 38.2% Year-Over-Year toRMB2,407 Million Adjusted Diluted Non-IFRS EPS Up by 19.7% to RMB1.46[1] SHANGHAI, March 24, 2020 /PRNewswire/ -- WuXi AppTec Co., Ltd. ...

2020-03-24 18:56 6833

OncoQuest Announces Publication of Two Reports Related to Oregovomab Phase 2 Clinical Trial, the Company's Lead Investigational Drug in Frontline Ovarian Cancer

EDMONTON, Alberta, March 24, 2020 /PRNewswire/ -- OncoQuest Inc. ("OncoQuest" or the "Company"), a privately held, cancer immunotherapy company today announced the publication of two reports relating to the recently completed Phase 2 trial conducted in the US andItaly utilizing oregovomab, the Co...

2020-03-24 18:00 1767

FOTRIC's Infrared Thermal Imaging Technology

SHANGHAI, March 24, 2020 /PRNewswire/ -- FOTRIC's fully automated infrared temperature detectors have been delivered to thousands of sites in an effort to screen abnormal body temperatures due to the recent pandemic. Infrared thermal imaging technology's advantages include all-weather imaging, m...

2020-03-24 17:00 1201

Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States

SUZHOU, China, and ROCKVILLE, Md., March 23, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the global Phase Ib/I...

2020-03-24 12:30 3640

Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States

SUZHOU, China, and ROCKVILLE, Md., March 23, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the global Phase Ib/I...

2020-03-24 12:24 3803

Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States

SUZHOU, China, and ROCKVILLE, Md., March 23, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the global Phase Ib/I...

2020-03-23 19:00 1654

Drug Registration Approval Granted for Sihuan Pharmaceutical's Pediatric Compound Amino Acid Injection (18AA-II)

HONG KONG, March 23, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that drug registration approval has been granted by the National Medical Products Administ...

2020-03-23 17:57 5078

CMAB Biopharma Resumes Full-Scale Operation Following the Coronavirus Disease 2019 (COVID-19) Outbreak

SUZHOU, China, March 23, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), has continued to monitor the development of the COVID-19 pandemic and has taken proactive measures to primarily protect the health of our employees worldwide. Based on our continuous assessment and management of ...

2020-03-23 08:00 3065

IMG Launches COVID-19 Resources to Answer Questions and Keep You Informed

INDIANAPOLIS, March 21, 2020 /PRNewswire/ -- As the circumstances surrounding the COVID-19 outbreak continue to escalate globally, IMG®'s number one priority is the health and safety of all their constituents. IMG has extensive experience working with governments and medical organizations during...

2020-03-21 07:05 2916

Bitdefender Offers Enterprise-Grade Security at Zero-cost to Healthcare Organizations

Bitdefender is committed to Aid Healthcare Professionals as Attacks Quadruple During COVID-19 Pandemic BUCHAREST, Romania and SANTA CLARA, California, March 21, 2020 /PRNewswire/ -- Bitdefender, a leading global cybersecurity company protecting over 500 million systems worldwide, today announced...

2020-03-21 04:01 2769

European and U.S. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses by Sartorius

GOTTINGEN, Germany, March 20, 2020 /PRNewswire/ -- On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher businesses by Sartorius. Both approvals are an important milestone for the transaction ...

2020-03-20 20:36 9467

Gencurix Releasing New Coronavirus Diagnostic Kit in the EU

SEOUL, South Korea, March 20, 2020 /PRNewswire/ -- A new diagnostic kit for the COVID-19, developed by Gencurix (KONEX 229000), will be available soon in Europe. GenePro COVID-19 Detection Test, developed in accordance to the WHO (World Health Organization) guidance for 'Laboratory testing for 2...

2020-03-20 16:23 2555

Prof. Oliver Sartor Joins Clarity's Advisory Board

SYDNEY, March 20, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Prof.Oliver Sartor has joined Clarity's Advisory Board. Prof. Sartor is a medical oncologist and an internationally recognised exp...

2020-03-20 12:29 2370

Federal Circuit Affirms Alfred E. Mann Foundation's $268M Win Against Cochlear

Decision marks major victory for nonprofit research foundation in long-running patent dispute LOS ANGELES, March 20, 2020 /PRNewswire/ -- The U.S. Court of Appeals for the Federal Circuit has affirmed a$268 million award in favor of the Alfred E. Mann Foundation for Scientific Research (AMF) in ...

2020-03-20 05:00 2228

Zhejiang Hisun Pharmaceutical Co. Ltd.: Favipiravir Works - Preliminary Clinical Studies Suggest Positive Effects on COVID-19 Patients

ZHEJIANG, China, March 20, 2020 /PRNewswire/ -- Since the outbreak of COVID-19, people around the globe have been eagerly awaiting a real breakthrough on its treatment. Fortunately, a silver lining seems finally to be showing up.

2020-03-20 03:50 4204

Zhejiang Hisun Pharmaceutical Co. Ltd.: Favipiravir Works - Preliminary Clinical Studies Suggest Positive Effects on COVID-19 Patients

AGC Biologics to Participate in Virtual BIO-Europe Spring

AGC Biologics Sponsors 14th Annual BIO-Europe Spring Conference SEATTLE, March 20, 2020 /PRNewswire/ -- AGC Biologics is pleased to be a gold sponsor of BIO-Europe Spring,Europe's largest springtime biotech partnering event. In order to ensure the health of all those participating, the event will...

2020-03-20 03:43 3059